Jamie Reed, RQAP-GCP

Jamie Reed, RQAP-GCP has over 25 years of experience in the pharmaceutical and biotechnology industries. From 1996 to 1998, Jamie was a Senior Clinical Research Associate at Amylin Pharmaceuticals. From 1998 to 2004, Jamie was the Senior Director at SCIREX Corporation, where they were responsible for oversight and process management of Clinical Quality Management (CQM). From 2004 to 2005, Jamie was a Consultant at Amgen and then became Senior Director at Bioniche Global Learning, managing rater training and other educational operations. From 2005 to 2008, Jamie was a Quality Compliance Consultant at NexBio, developing Clinical Quality Systems and providing monitoring report review and monitoring oversight for contract monitors. From 2008 to 2009, Jamie was the Sr. Manager, QA Compliance at Optimer Pharmaceuticals. From 2009 to 2012, Jamie was the Director, Quality Assurance at Ambit Biosciences. From 2012 to 2015, Jamie was the Director, Quality Assurance at La Jolla Pharmaceutical Company, where they implemented and managed GXP quality systems and were responsible for GCP and GLP inspection readiness. From 2015 to 2019, Jamie was the Senior Director, Clinical QA and then Director, Clinical QA at Biosplice Therapeutics. Jamie is currently the Sr. Director, Head of Quality Assurance at Reneo Pharmaceuticals.

Jamie Reed, RQAP-GCP received their Bachelor of Arts in Psychology from UC San Diego in 1991 and their Master of Business Administration from the University of Redlands in 1997.